Jennison Associates’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.7M | Sell |
270,366
-23,391
| -8% | -$1.02M | 0.01% | 369 |
|
|
2025
Q1 | $11M | Sell |
293,757
-18,634
| -6% | -$696K | 0.01% | 376 |
|
|
2024
Q4 | $14.2M | Sell |
312,391
-220
| -0.1% | -$9.97K | 0.01% | 370 |
|
|
2024
Q3 | $18.4M | Buy |
312,611
+6,533
| +2% | +$384K | 0.01% | 350 |
|
|
2024
Q2 | $12M | Buy |
306,078
+3,186
| +1% | +$125K | 0.01% | 370 |
|
|
2024
Q1 | $20.1M | Buy |
302,892
+199,148
| +192% | +$13.2M | 0.01% | 341 |
|
|
2023
Q4 | $2.9M | Buy |
+103,744
| New | +$2.9M | ﹤0.01% | 441 |
|